Peapack-Gladstone Financial Corp’s ResMed RMD Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,290	Closed	-$308K	–	333
2015 Q1	$308K	Hold	4,290	–	–	0.02%	274
2014 Q4	$240K	Sell	4,290 -72,940	-94%	-$3.81M	0.02%	284
2014 Q3	$3.81M	Buy	77,230 +1,365	+2%	+$69.5K	0.28%	95
2014 Q2	$3.84M	Buy	75,865 +9,345	+14%	+$463K	0.29%	98
2014 Q1	$2.97M	Buy	66,520 +360	+0.5%	+$16.2K	0.23%	105
2013 Q4	$3.11M	Sell	66,160 -2,550	-4%	-$129K	0.25%	100
2013 Q3	$3.63M	Buy	+68,710	New	+$3.33M	0.32%	88

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Peapack-Gladstone Financial Corp's RMD Position: Q2 2015 in Review

Peapack-Gladstone Financial Corp sold out of ResMed (RMD) in Q2 2015, closing a stake of 4,290 shares — an estimated $308K sold.

Peapack-Gladstone Financial Corp first reported a position in RMD in Q3 2013 and held it in 7 quarters. The position peaked at $3.84M in Q2 2014. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

Peapack-Gladstone Financial Corp reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
Peapack-Gladstone Financial Corp sold 4,290 ResMed shares in Q2 2015, an estimated $308K.
Peapack-Gladstone Financial Corp first reported a position in ResMed in Q3 2013 and held it in 7 quarters.
Peapack-Gladstone Financial Corp's ResMed position peaked at $3.84M in Q2 2014.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2015, filed 13 Aug 2015.